Letter to Mr. Andy Slavitt, Acting Administrator for the Centers for Medicare and Medicaid Services - Provide Insight on the Misclassification of the EpiPen by Mylan Pharmaceuticals

Letter

Only available in PDF format; please see source to view document.


Source
arrow_upward